EXP2550 PUR7776 Illumina Final.pdf

PUR 7776 (Revised 07/2022) Page 1 of 2 Incorporated by Reference: Rule 60A-1.045, F.A.C.

DESCRIPTION OF INTENDED

SINGLE SOURCE PURCHASE

(PUR 7776)

This description of commodities or contractual services intended for purchase from a single source is posted in accordance with Sections 120.57(3) and 287.057(3), Florida Statutes (F.S.), and will remain posted for a period of at least 15 business days.

Commodity or Contractual Service Required (commodity or United National Standard Products and Services Code (NSPSC), manufacturer, model, and description, as appropriate):

41113000 Chemical evaluation instruments and supplies 41113600 Electrical measuring and testing equipment and accessories 41116000 Clinical and diagnostic analyzer reagents 81101706 Analyzer, Laboratory, Maintenance Service

Quantity or Term (as appropriate):

3 years

Requestor (division, bureau, office, individual, as appropriate):

Department of Health, Public Health Laboratories (BPHL)

Performance and/or Design Requirements (e.g. intended use, function or application, compatibility, requirements; reference to policy, rule, statute or other act of the Legislature, etc., as appropriate):

The Department of Health's, Bureau of Public Health Laboratories has the need to purchase the Illumina MiSeq®, iSeq ®, and NextSeq ® system reagents and services for the identification of nucleic acid sequences. These instruments and reagents will support the outbreak detection

AGENCY: Florida Department of Health (Department)

TITLE: Illumina reagents and services Short description of the commodity or services desired: Reagents and equipment needed to perform validated testing of clinical samples

CONTACT

Name: Bill Zimmerman Address: 4052 Bald Cypress Way, Tallahassee, FL, 32399 Telephone: (850) 617-5894 Email: bill.zimmerman@flhealth.gov

Internal tracking number, if any: EXP2550

Date posted: 2/28/2024 Last day for receipt of information: 3/20/2024

PUR 7776 (Revised 07/2022) Page 2 of 2 Incorporated by Reference: Rule 60A-1.045, F.A.C.

activities for enteric and viral diseases and are required by the Centers for Disease Control and Prevention (CDC).

In accordance with Chapter 60A-1.045, Florida Administrative Code, the Florida Department of Health, BPHL, requests authorization to purchase, as a single source, the MiSeq®, iSeq ®, and NextSeq ® System reagents and services from Illumina, Inc.

Intended Single Source:

Illumina, Inc.

Estimated Dollar Amount:

$6,000,000.00

Justification for single source acquisition (what is necessary and unique about the product, services or source; steps taken to confirm unavailability of competition, as appropriate):

• Illumina, Inc is the sole manufacturer and distributor of MiSeq®, iSeq ®, and NextSeq ® system reagents and services.

• Illumina is the only CDC approved kit used for SARS CoV-2, HIV, Hepatitis A, TB, and foodborne pathogens that examines mutations and includes reagents, instrumentation, and software. It is in the best interest of the state to maintain continuity by using these specialized reagents and services needed for the required testing.

Approved By (names & titles, as appropriate, e.g., requestor, requestor management, information systems, budget, purchasing):

Allegra Small, Purchasing Director

Prospective vendors are requested to provide information regarding their ability to supply the commodities or contractual services described. If it is determined in writing by the agency, after reviewing any information received from prospective vendors, that the commodities or contractual services are available only from a single source, the agency shall provide notice of its intended decision to enter a single-source purchase contract in the manner specified in Rule 60A-1.045, Florida Administrative Code, and section 120.57(3), F.S.